SCHEMBL8880294

SCHEMBL8880294

O=S1(=O)c2cccc3cccc(c23)N1CCCCBr

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.69
HSD17B10 Q99714 2/20 0.69
ALDH1A1 P00352 2/20 0.67
TDP1 Q9NUW8 1/20 0.67
HDAC3 O15379 1/20 0.63
HDAC4 P56524 1/20 0.63
HDAC1 Q13547 1/20 0.63
HDAC7 Q8WUI4 1/20 0.63
HDAC2 Q92769 1/20 0.63
HDAC10 Q969S8 1/20 0.63
HDAC11 Q96DB2 1/20 0.63
HDAC8 Q9BY41 1/20 0.63
HDAC6 Q9UBN7 1/20 0.63
HDAC9 Q9UKV0 1/20 0.63
HDAC5 Q9UQL6 1/20 0.63
NPC1 O15118 1/20 0.62
HPGD P15428 1/20 0.61
HTR7 P34969 7/20 0.60
POLB P06746 1/20 0.57
HTR1A P08908 4/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8881466 0.99 KDM4E (0.67) KDM4EHSD17B10ALDH1A1TDP1HDAC3
SCHEMBL6598227 0.95 KDM4E (0.68) KDM4EHSD17B10ALDH1A1TDP1HDAC3
SCHEMBL9757630 0.87 KDM4E (0.71) KDM4EHSD17B10ALDH1A1TDP1HDAC3
SCHEMBL14288510 0.85 KDM4E (0.81) KDM4EHSD17B10ALDH1A1TDP1HDAC3
SCHEMBL14288509 0.85 KDM4E (0.85) KDM4EHSD17B10ALDH1A1TDP1HDAC3
SCHEMBL9635395 0.84 KDM4E (0.68) KDM4EHSD17B10ALDH1A1TDP1HDAC3
SCHEMBL14825304 0.82 KDM4E (1.00) KDM4EHSD17B10ALDH1A1TDP1HDAC3
SCHEMBL9635285 0.80 KDM4E (0.72) KDM4EHSD17B10ALDH1A1TDP1HDAC3
SCHEMBL21857973 0.80 KDM4E (0.72) KDM4EHSD17B10ALDH1A1TDP1HDAC3
SCHEMBL14288497 0.80 KDM4E (1.00) KDM4EHSD17B10ALDH1A1TDP1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997046525-A1 5-ALKOXY-TRYPTAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS 5-HT1D RECEPTOR AGONISTS ALLELIX BIOPHARMACEUTICALS INC. (CA) 1997-12-11 WO disclosed
US-5654431-A EXHIBIT SELECTIVITY TOWARDS 5-HYDROXYTRYPTAMINE RECEPTORS OF BRAIN CELLS ALLELIX BIOPHARMACEUTICALS INC. (CA) 1997-08-05 US disclosed
US-5585392-A TREATING OR PREVENTING STROKES BAYER AKTIENGESELLSCHAFT (DE) 1996-12-17 US disclosed
US-5506246-A Method for treating depression using substituted aminomethyltetralins and their heterocyclic analogues BAYER AKTIENGESELLSCHAFT (DE) 1996-04-09 US disclosed
US-5453437-A 1,3-disubstituted pyrrolidines BAYER AKTIENGESELLSCHAFT (DE) 1995-09-26 US disclosed
US-5300523-A Binding serotonin receptors, treating nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1994-04-05 US disclosed
US-5274097-A A 1-N-heterocyclic alkylene-3-carbo or heterocyclic ring oxypyrrolidine derivative BAYER AKTIENGESELLSCHAFT (DE) 1993-12-28 US disclosed
US-5137901-A For binding 5-HT 1 receptors; treating central nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1992-08-11 US disclosed